Signal #144405 · SEC 8-K

$CABA SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $CABA filing catalyst

Why did $CABA trigger an AI stock catalyst alert?

$CABA triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.0/10). Headline: Cabaletta Bio Reports Q3 2026 Net Loss of $53M with BLA Target Pushed to 1Q28. Key points: - Q3 2026 net loss widened to ~$53M ($0.28 per share) vs $44M ($0.44 per share) in prior-year period. - Cash, cash equivalents and short-term investments stood at $299.4M as of September 30, 2026. - RESET-Myositis adult topline results expected 2H27 with BLA filing targeted for 1Q28.

How did $CABA stock react after the SEC filing?

After the SEC 8-K for $CABA, observed market reaction: T0 price $1.42. Past moves do not guarantee future results.

Where can I get real-time $CABA SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $CABA via Telegram and the VIP Web Terminal from €10/month.

$CABA

$CABA – Cabaletta Bio Reports Q3 2026 Net Loss of $53M with BLA Target Pushed to 1Q28

Cabaletta Bio, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $CABA

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (-1.0 / 10)

Q3 2026 net loss widened to ~$53M ($0.28 per share) vs $44M ($0.44 per share) in prior-year period.
Cash, cash equivalents and short-term investments stood at $299.4M as of September 30, 2026.
RESET-Myositis adult topline results expected 2H27 with BLA filing targeted for 1Q28.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →